A Study of A-101 Solution in Subjects With Common Warts.

Common Warts Clinical Trial

Official title:
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Solution in Subjects With Common Warts.

Status Completed

Clinical Trial Summary

This is a randomized, double-blind, vehicle-controlled, parallel-group study with 3 treatment groups.

Clinical Trial Description

This is a randomized, double-blind, vehicle-controlled, parallel-group study with 3 treatment groups. During Visit 1, the Investigator will identify 1 eligible common wart on the trunk or extremities on each subject. The wart will be treated up to a maximum of 8 times at 1 week intervals during the study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02669862
Study type	Interventional
Source	Aclaris Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	December 21, 2015
Completion date	September 16, 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01286441` - A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts	Phase 2
Completed	`NCT02798419` - Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts	Phase 2
Active, not recruiting	`NCT02640820` - Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)	Phase 2
Completed	`NCT02650466` - Nanopulse Efficacy Study for the Treatment of Common Warts	N/A
Not yet recruiting	`NCT03166137` - Carbon Dioxide Laser and Cryotherapy in Treatment of Warts	N/A
Completed	`NCT02748902` - Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.	Phase 1